ClearPoint Neuro (CLPT) Invested Capital (2015 - 2020)

ClearPoint Neuro (CLPT) posted Invested Capital of $73985.0 for Q3 2020, down 75.06% sequentially from $296677.0 in Q2 2020.

ClearPoint Neuro (CLPT) Invested Capital (2015 - 2020) Analysis & Trends

ClearPoint Neuro has reported Invested Capital for 5 years, with the latest figure at $73985.0 in Q3 2020.

Quarterly Invested Capital changed N/A year-over-year to $73985.0 in Q3 2020, while the trailing twelve-month figure through Jun 2021 was $73985.0 (down 75.06% YoY) and the FY2017 annual result came in at $7.0 million, changed 0.0% from the prior year.
Invested Capital declined to $73985.0 in Q3 2020 per CLPT's latest filing, from $296677.0 in the prior quarter.
Over five years, Invested Capital peaked at $7.0 million in Q4 2016 and troughed at $73985.0 in Q3 2020.
A 4-year average of $3.1 million and a median of $2.0 million in 2018 frame the typical range for Invested Capital.
The sharpest annual moves came in 2016 and 2017: Invested Capital jumped 65.1% in 2016, then changed 0.0% in 2017.
Over 4 years, Invested Capital stood at $7.0 million in 2016, then changed by 0.0% to $7.0 million in 2017, then tumbled by 71.33% to $2.0 million in 2018, then slumped by 96.3% to $73985.0 in 2020.
According to Business Quant data, Invested Capital over the past three periods registered $73985.0, $296677.0, and $2.0 million for Q3 2020, Q2 2020, and Q2 2018 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Abbott Laboratories	199.44 Bn	193.84 Bn	7.27 Bn	3.01 Bn
2	Stryker	127.32 Bn	123.85 Bn	4.50 Bn	750.00 Mn
3	Medtronic	118.87 Bn	109.65 Bn	6.41 Bn	1.79 Bn
4	Boston Scientific	73.47 Bn	72.93 Bn	3.85 Bn	1.71 Bn
5	Edwards Lifesciences	51.90 Bn	47.65 Bn	1.35 Bn	-
6	Dexcom	34.30 Bn	32.36 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.74 Bn	31.63 Bn	2.18 Bn	2.00 Mn
8	Koninklijke Philips	26.35 Bn	23.03 Bn	4.55 Bn	1.34 Bn
9	Steris	23.05 Bn	22.56 Bn	684.20 Mn	243.40 Mn
10	ClearPoint Neuro	465.77 Mn	436.37 Mn	6.71 Mn	-

Download Data